Today, on 4 July, JSC Grindeks submitted to Nasdaq Riga the company’s Annual Report and the Corporate Social Responsibility Report for the year 2015, to...
1. Reports of Board, Supervisory Council, Audit Committee and statement of Sworn auditor To take notice of the reports of the Board, the Supervisory Council,...
Today, on 27 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first quarter of 2016 to Nasdaq Riga. Non-audited financial results...
Today, on 29 April, the JSC Grindeks submitted the audited consolidated financial statements of 2015 to Nasdaq Riga. Audited financial results indicate that the Group’s...
JSC Grindeks, the manufacturer of Mildronate® (meldonium), has submitted an open letter to the World Anti-Doping Agency (WADA). According to the JSC Grindeks, WADA has...
There’s really no evidence that there’s any performance enhancement from meldonium, said Don Catlin, a long-time anti-doping expert and the scientific director of the Banned...
Despite Grindeks submitted arguments, evidence and justifications, the World Anti-Doping Agency (WADA) included meldonium in the Prohibited list. In accordance with the results of the...
Today, on 26 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2015 to Nasdaq Riga. Non-audited financial results indicate that the Group’s...
